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INTRODUCTION 
Wallner B K et al introduced MRCP in 1991, using a breath 
hold, two dimensional T2 weighted gradient echo sequence using 
steady state free precession (SSFP). 
Laubenberger in 1995 introduced Modified Fast Spin Echo 
(FSE) sequences. 
TECHNIQUE 
MRCP is usually performed with heavily T2-weighted 
sequences by using fast spin-echo or single-shot fast spin-echo 
software and both a thick-collimation (single-section) and thin-
collimation (multisection) technique with a torso phased-array coil.  
By using heavily T2- weighted sequences, the signal of static  
or slow- moving fluid- filled structures such as the bile and 
pancreatic ducts is greatly increased, resulting in increased duct-to-
back- ground contrast. 
The coronal plane is used to provide a cholangiographic 
display, and the axial plane is used to evaluate the pancreatic duct 
and distal common bile duct. 
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Single-shot fast spin-echo is a newer and more rapid MRCP 
sequence that can be performed in a single breath hold, thereby 
significantly reducing motion artifacts and increasing image 
quality. As a result of less motion artifact (noise) with single-shot 
fast spin echo MRCP, the signal-to-noise ratio increases compared 
with that of fast spin-echo MRCP. 
SERIES-1: LOCATOR 
SSFSE shows the abdominal anatomy well. It is done 
preferably with a breathhold in expiration so it can be used for 
planning Series-2 and 3 Axial T2 and T1. With SSFSE use a 
sufficiently large FOV (ie. set FOV to width of patient) to eliminate 
wrap-around artifact. 
SERIES-2: AXIAL T2 
This sequence identifies hepatic, pancreatic and other lesions. 
It shows the common bile duct to guide acquisition of coronal 
oblique MRCP sequence. 
SERIES 3: AXIAL IN-PHASE (FAT SATURATION) 
This sequence is excellent for evaluating pancreatic 
pathology and especially for identifying pancreatic masses.  
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THICK SLAB 
The first step in performing MRCP is to localize the biliary 
tract and pancreatic duct. 
During the single-section acquisition, we can obtain six or 
seven 20-mm-thick coronal sections through the porta hepatis and 
rotating around a point anterior to the portal vein.  
Thick slab MRCP technique permits depiction of the majority 
of the biliary tract and pancreatic duct on a single image. 
THIN SLAB 
During the thin-collimation, multisection acquisition, 5-mm 
sections  in the straight coronal plane are obtained with a 100% 
intersection gap and a gap-and-fill technique during one breath hold 
of less than 30 seconds. 
1) Prescribe this series from the axial T2 series. Select an image 
which shows the common bile duct (CBD). 
2) Use 5 mm thick with 0 gap slices 
3) 15 slices takes about 30 seconds, which is reasonable breath 
hold. 
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4) Coronal View: Set the imaging volume from posterior to the 
CBD as it passes through the head of the pancreas to anterior 
to the porta hepatis. Ideally the entire gallbladder should be 
included within the 15 slices. 
5) RAO: Rotate 20-30 counterclockwise and include the CBD. 
6) LAO: Rotate 20-30 clockwise centered on the CBD and 
gallbladder should be included in the view. 
7) Axial: Set the axial plane at 4-5 mm slice thickness which  is 
useful in patients with suspected of pancreatic divisum. 
ANATOMY OF BILIARY TREE IN MRCP 
lntra hepatic biliary radicle join together to form segmental 
ducts which join together to form the right and left hepatic ducts, 
Segmental ducts are demonstrated in 90% of MRCPs. Right and left 
hepatic ducts are visualised in 96% of MRCPs. MRCP is 95% 
accurate in differentiation of normal from dilated ducts. 
The common hepatic duct is formed by the confluence of 
right and left hepatic ducts in the portahepatis. The normal common 
hepatic duct measures less than 7mm. The cystic duct which arises 
from the neck of the gall bladder joins the common hepatic duct to 
 5
form the common bile duct. The normal common bile duct diameter 
is upto 10mm in diameter. 
NORMAL PANCREATIC DUCT 
Pancreatic duct is usually not seen in its entirety on a single 
source image,because the pancreatic duct is curved and obliquely 
oriented.So an image with thick collimation (2–3 cm) can 
demonstrate the duct in its entirety is needed. 
NORMAL VARIANTS IN PANCREATIC DUCT COURSE 
The normal pancreatic duct course varies considerably. Four 
types have been described, descending, vertical, sigmoid and loop. 
The most common is the descending variety. The sigmoid type of 
course can be mistaken for extrinsinc mass effect, the vertical type 
may be mistaken for the common bile duct and the loop type for a 
stricture. 
ERCP TECHNIQUE 
Endoscopic retrograde cholangiopancreatography (ERCP), 
developed in the 1970s, was initially designed for diagnostic 
imaging of the biliary tree. Therapeutic biliary applications for 
ERCP developed soon after its initial introduction, and pancreatic 
applications soon followed. ERCP is performed using a side-
 6
viewing duodenoscope, which allows for views of the medial wall 
of the duodenum, including an en face view of the ampulla. An 
instrument channel in the duodenoscope enables cannulation of the 
ampulla of Vater under direct visualization, and injection of 
contrast into the bile duct and pancreatic duct to obtain diagnostic 
images.  
The clinical applications of MRCP are numerous and include 
the diagnosis of common bile duct stones; malignancies of the 
pancreaticobiliary tract; congenital anomalies such as choledochal 
cysts, aberrant bile ducts, and pancreas divisum; primary sclerosing 
cholangitis (PSC); acute and chronic pancreatitis; and gallbladder 
disease such as stones and carcinoma. MRCP is also useful in the 
evaluation of patients who have experienced an incomplete or 
failed ERCP attempt and in the evaluation of patients in whom the 
performance of ERCP is difficult or impossible due to surgical 
alterations of the  gastrointestinal tract. 
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CAUSES OF BILIARY OBSTRUCTION 
Anatomical 
location Malignant Benign 
Hilar Gallbladder 
carcinoma 
Hepatocellular 
carcinoma 
 
low/midduct Pancreatic 
carcinoma 
Periampullary 
carcinoma 
Pancreatitis [acute or 
chronic] 
either Cholangio 
Carcinoma 
Metastases 
Lymphoma 
Benign biliary 
tumors 
Stones 
Mirizzi syndrome 
Postoperative strictures 
Primary sclerosing 
cholangitis 
Other cholangiopathy 
Hemobilia 
Parasites 
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AIM OF THE STUDY 
A study on accuracy of magnetic resonance cholangio 
pancreatography (MRCP) Vs endoscopic retrograde cholangio 
pancreatography (ERCP) in the evaluation of pancreaticobiliary 
disorders. 
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REVIEW OF LITERATURE 
1.Hurter, D.; De Vries, C.; Potgieter, P.H.; Barry, R.; Botha, 
F.J.H.; Joubert, G. 2008 et al; Fifty-two patients with suspected 
pancreatobiliary pathology were included in this prospective 
observational study. MRCP was performed in the 24-hour period 
prior to ERCP. MRCP had sensitivity, specificity, positive and 
negative predictive values of 87%, 80%, 83.3% and 84.2% 
respectively for choledocholithiasis. 
2. Sica GT, Miller FH, Rodriguez G, et al.2002, In thier  study, 
the diagnosis of chronic pancreatitis was established by a 
combination of history, symptoms, pancreatic enzyme 
abnormalities CT, and ERCP. Twenty-two out of twenty-three 
patients with chronic pancreatitis had ERCP. The severity of the 
chronic pancreatitis was not specified.The same patients were 
subjected to MRCP. Abnormality on fat suppressed T1-weighted 
images was present with greater frequency and magnitude than 
wasabnormality on arterial or portal phase enhancedsequences. The 
sensitivity to pancreatitis using all sequences was 92%, but 
specificity was only 50%, 
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  3. Do Hyun Park MD, Myung-Hwan Kim MD Aug 2005 et al  
The study design was an 8-year retrospective survey conducted at a 
tertiary referral center, Asan Medical center (University of Ulsan 
College of Medicine, Seoul, Korea). There were 72 patients with 
choledochal cysts. All patients underwent both MRCP and ERCP. 
MRCP findings were compared with those of ERCP as the criterion 
standard.The overall detection rate of MRCP for choledochal cysts 
was 96% (69/72). The sensitivity, the specificity, the positive 
predictive value, and the negative predictive value of MRCP for 
classifying choledochal cysts according to Todani's classification 
were 81%, 90%, 86%, and 86% in type I, respectively; 73%, 100%, 
100, and 95% in type III, respectively; 83%, 
4. Mi-suk park,Taekyoung kim-RSNA 2004 et al; To 
retrospectively evaluate criteria for differentiating extrahepatic bile 
duct cholangiocarcinoma from benign cause of stricture at magnetic 
resonance cholangiopancreatography (MRCP) and to compare 
diagnostic accuracy with this modality versus endoscopic 
retrograde cholangiopancreatography (ERCP).  MRCP and ERCP 
images in 50 patients (27 with cholangiocarcinoma [18 men, nine 
women; mean age, 58 years] and 23 with benign cause of stricture 
[13 men, 10 women; mean age, 60 years]) were retrospectively 
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reviewed to assess the appearance of bile duct strictures. Final 
diagnosis was based on surgical or biopsy findings. Strictures were 
described according to their imaging appearance (irregular or 
smooth margins, asymmetric or symmetric narrowing, abrupt 
narrowing or gradual tapering, and presence or absence of double-
duct sign). Sensitivity, specificity, and accuracy of MRCP and 
ERCP were calculated by using ratings of confidence in image-
based diagnosis. Lengths of stricture were and compared by using 
the Student t test. Among cholangiographic criteria for malignant 
biliary stricture, irregular margins and asymmetric narrowing were 
more common in cholangiocarcinomas (24 [89%] of 27 patients) 
than in benign strictures (six [26%] and eight [35%] of 23 patients, 
respectively). Sensitivity, specificity, and accuracy of the two 
methods for differentiation of malignant from benign causes of 
biliary stricture were 81% (22 of 27), 70% (16 of 23), and 76% (38 
of 50), respectively, for MRCP and 74% (20 of 27), 70% (16 of 23), 
and 72% (36 of 50), respectively, for ERCP. Mean length (± 
standard deviation) of cholangiocarcinomas was 30.0 mm ± 8.5, 
and that of benign strictures was 13.6 mm ± 9.1 (P < .001).  
MRCP compared to diagnostic ERCP for diagnosis when biliary 
obstruction is suspected: 2006 Kaltenthaler et al; A systematic review 
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of studies comparing MRCP to diagnostic ERCP in patients with 
suspected biliary obstruction was conducted. Sensitivity, 
specificity, likelihood ratios, were reported. 25 studies were 
identified reporting several conditions including 
choledocholithiasis (18 studies), malignancy (four studies), 
obstruction (three studies), stricture (two studies) and dilatation 
(five studies). Three of the 18 studies reporting choledocholithiasis 
were  excluded   from the analysis due to lack of data, or 
differences in study design. The sensitivity for the 15 studies of 
Choledocholithiasis ranged from 0.50 to 1.00 while specificity  
ranged from 0.83 to 1.00. The positive likelihood ratio ranged: 
from 5.44–47.72 and the negative likelihood ratio for the 15 studies 
ranged from 0.00–0.51. Significant heterogeneity was found across 
the 15 studies so the sensitivities and specificities were summarised 
by a Receiver Operating Characteristic (ROC) curve. For 
malignancy, sensitivity ranged from 0.81 to 0.94 and specificity 
from 0.92 to 1.00. Positive likelihood ratios ranged from 10.12 to 
43 and negative likelihood ratios ranged from 0.15 to 0.21. 
6.Guibaud L, Bret PM, Reinhold C, Atri M,BarkunAN.1995 et 
al; In their study MRCP was comparable with ERCP in detection of 
obstruction, with a sensitivity, specificity, and accuracy of 91%, 
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100%, and 94%, respectively.It is 94% sensitive and 93% specific 
for detection of dilatation (7). MRCP play arole in the preoperative 
work-up of these patientsundergoing biliary surgery(8). Because of 
the very high signal-to-backgroundratio of bile, calculi are readily 
identified as darkfilling defects within the high-signal-intensity 
fluid at MRCP. Calculi as small as 2mm in diameter can be 
visualized (9), andthe accuracy of stone detection is greater with 
single-shot fast spin-echo techniques because ofthe reduction of 
motion and susceptibility artifacts.Small calculi may not cause 
secondary dilatation of the ducts (10) and are best seen on the axial 
images (10). The differential diagnosis of filling defects inthe bile 
ducts most commonly includes stones and air bubbles; however, 
neoplasms, bloodclots, concentrated bile, metallic stents, 
flowvoids, and susceptibility artifact from surgicalclips must be 
excluded (11).  
7.Holzknecht N,Gauger J, Sackmann M, et al. In their 
comparative study  MRCP showed more accurate assessment of 
ductal caliber in the physiologicstate, unlike ERCP, with which 
ductalcaliber may be overestimated because of injectionpressure 
.The determination of the sensitivity and specificityof ERCP in the 
diagnosis of choledocholithiasisis difficult because ERCP 
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is considered thestandard of reference for common bile duct stone 
detection. In an analysis of 72 patients studied with intraoperative 
cholangiography and ERCP, Frey et al [11_}found a sensitivity of 90% 
and a specificity of98% for ERCP in the setting of 
choledocholithiasis.. 
.Liu T,Consorti E,Kawashima A,et al. studied ERCP  was 
probably best reserved for those with increased suspicion of CBD 
stones by noninvasive criteria that will likely require therapy[12]. 
.Such noninvasive criteria can help to determine the optimal patient 
to undergo ERCP (for both diagnosis and therapy) without further 
testing. In patients with acute cholangitis, ERCP has improved the 
clinical course, should be performed within 24 hours of 
presentation, and is less morbid than percutaneous transhepatic 
cholangiography or CBD exploration [13]. Endoscopic retrieval of 
CBD stones and clearance of the duct is successful in over 90% of 
cases on the first attempt [14,15]. A variety of adjunctive 
techniques may be utilized, which include sphincterotomy,basket 
extraction, balloon extraction,mechanical lithotripsy, and 
electrohydraulic  lithotripsy. All can be performed via the 
instrument channel of the duodenoscope. In the case of CBD stones 
that cannot be removed using standard ERCP techniques 
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(sphincterotomy with balloon or basket extraction) stents have 
proven useful. Stents, placed during ERCP, provide biliary drainage 
in the setting of unextractable stones and may help fragment large 
stones, allowing for spontaneous or subsequent ERCP clearance. 
 Lopera JE, Sota JA,Munera F. et al  studied MRCP  was 
particularly well suited to the detection and staging of hilar  
cholangiocarcinoma because MRCP readily depicted  the length of 
the extrahepatic bile duct involved by the disease as well as the 
proximal extent of disease—an important factor in determining  
resectability [16]. In contrast to ERCP MRCP is particularly 
advantageous because it  depicts the ducts located  proximal and 
distal to a high-grade obstruction. This is possible because ductal 
depiction at MRCP simply relies upon the presence of fluid in the 
ducts and not on opacificationof the ducts with contrast material. 
Therefore, MRCP is useful in identifying multiple segmental 
obstructions of the intrahepatic ducts that may not be opacified at 
ERCP. The identification of isolated obstructions is helpful in 
providing a road map for planning percutaneous interventions. 
 More than 80% of bile duct strictures occur after an injury to 
the extrahepatic  bile ducts during a cholecystectomy (17,18), 
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MRCP has been shown to be comparable with  ERCP in 
demonstrating the location and extent of strictures of the 
extrahepatic bile duct, with sensitivities of 91%–100% (19,20).  
 Helzberg J,Peterson JM,Boyer JL. et al. studied Acute 
bacterial cholangitis and biliary stones maycomplicate PSC in up to 
one third of patients [21,22], Patients with PSC were at increased 
risk to develop  cholangiocarcinoma [23]. Given their 
underlyingdisease, this complication  was often difficult to 
diagnose noninvasively. ERCP provided a method for tissue 
sampling that is unavailable to other imaging modalities, and 
additionally provides means for palliativemeasures. 
Freeny PC,Bilbao MK,Katon RM.et al studied at MRCP, 
dilatation of both the pancreatic and bile ducts  was highly 
suggestive of a pancreatic head malignancy(24). 
 MRCP has been shown to be accurate in demonstrating the 
cause of obstruction, with positive  and  negative predictive values 
of 93% and 94%,respectively, for benign causes and 86% and98%, 
respectively, for malignant causes(6,25,7). MR cholangiography 
can demonstratethe presence and extent of strictures; allow 
determination of the resectability of the lesion; and provide a road 
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map for subsequent surgical, percutaneous, or endoscopic 
intervention.  
Sica GT, Braver J,Cooney MJ et al. In their comparative study 
Patients with severe acute pancreatitis and suspicion of CBD stones  
were benefited  from urgent ERCP with sphincterotomy [26,27].  
One cause of recurrent idiopathic acute pancreatitis include 
sphincter of Oddi dysfunction .ERCP may have a role in evaluating 
and treating patients with this disorder. Manometry studies of the 
biliary and pancreatic sphincter can be performed during ERCP, 
with subsequent endoscopic sphincterotomies with or without stent 
placements for treatment [28]. 
Primary role of MRCP in the evaluation of chronic 
pancreatitis lies in defining biliary and pancreatic duct anatomy and 
disease extent prior to surgical drainage procedures. MRCP is 
accurate in detecting common ductal manifestations of chronic 
pancreatitis such as dilatation, strictures, and stones ,as well as less 
common manifestations such as thoraco pancreaticfistulas  [29,30]. 
MRCP is well suited to the detection of pseudocysts not opacified 
at ERCP. In addition to depicting the morphologic changes of 
chronic pancreatitis, recent studies reveal the utility of MRCP in 
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assessing functional abnormalities of the exocrine pancreas. 
 Smits ME,,Rauws EA, Tytgat GN,et al Pancreatic duct stones, 
strictures, fistulas, chronic pain, and pseudocyst formation may 
complicate chronic pancreatitis. Endoscopic therapy retains an 
important role in the treatment of these complications. Pancreatic 
duct stones, which may obstruct the duct and cause or worsen 
pancreatitis, can be removed during ERCP [31,32]. Endoscopic 
dilation and stenting of strictures can provide temporary pain relief, 
but long-term results appear unsatisfactory due to stent occlusion 
[33]. Pancreatic duct leaks and fistulas may occur secondary to 
pancreatitis or trauma, and have been successfully managed using 
transpapillary stents [34]. 
Biliary-enteric anastomoses such as choledochojejunostomy, 
hepatico jejunostomy, and BillrothII anastomosis make it difficult 
or impossible to access the major papilla at endoscopy. In patients 
with such anastomoses, MRCP is the imaging modality of choice 
for the work-up of suspected pancreaticobiliary disease. It has been 
reported that MRCP is 100% sensitive in detection of anastomotic 
strictures and 90%sensitive in detection of biliary tract stones 
proximal to the anastomosis (35). MRCP is also 100% sensitive in 
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demonstrating the choledochojejunal anastomosis after a Whipple 
procedure. 
Mortele KJ Ros PR  2001 et al studied variations in the 
branching pattern of the intrahepatic bile ducts occur in 37% of 
individuals [36].MRCP performs well in the depiction of 
biliaryvariants [37,38]. These include accessory right and left 
hepatic ducts that enter the extrahepatic bile duct caudal to the 
confluence, trifurcation anomalies, cross-over anomalies such as 
the dorsocaudal branch of the right hepatic duct entering the central 
left hepatic duct, and cystic duct anomalies. MRCP play an 
important  role in the detection of biliary  variants  prior to 
laproscopic cholecystectomy. 
Bret PM ,Reinhold C ,Taourel P,1996 et al studied MRCP has 
100% accuracy in detection of pancreas divisum (39). 
Annularpancreas  is characterised by extension of pancreatic tissue 
completely surrounding the duodenum. on MRCP a definitive 
diagnosis can be offered. The pancreatic duct is seen circling 
around the duodenum. 
Although ERCP provides high-quality images of the 
pancreaticobiliary tract in many instances, failed or incomplete 
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ERCPs occur in up to 10% to 20% of all attempts. Failed or 
incomplete ERCPs  are  most often technical in nature, but may be 
related to anatomic abnormalities such as periampullary 
diverticula,duodenal stenosis, or obstructing gastric 
neoplasms(40).MRCP is useful in detecting and excluding 
abnormalities in this patient population. 
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MATERIALS AND METHODS 
Study design: prospective study 
Place: Barnard Institute of Radiology, Rajiv Gandhi 
Government General Hospital, Madras medical college, Chennai -3 
Collaborating Unit: Department of Medical Gastroenterology, 
Rajiv Gandhi Government General hospital. Madras Medical 
College, Chennai-3. 
Study population: 50 patients were included in the study. The 
study group consisted of  male and female patients, between the age 
of 22 to 65 years (with a mean age of 43 years). For all 50 patients 
per operative findings were obtained.The study was Approved by 
the  institutional ethical committee . 
Sample Size:50  
Study period-2009 -2011 
 Consent : Informed  consent obtained  from all patients. 
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INCLUSION CRITERIA 
 Patients who were having a history of obstructive jaundice, 
pain abdomen and cholangitis  
 50 patients with  these symptoms underwent  MRCP using  
1.5 Tesla Siemens  Symphony  MRI scanner. 
 The results were compared with ERCP.  
EXCLUSION  CRITERIA 
 Pts  with claustrophobia, 
 Pts  with cardiac pacemakers, 
 Pts  with metallic implants, 
Hemodynamically unstable patients. 
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MRCP SEQUENCES 
T2 Haste  
HASTE thick slab 
HASTE thin slice 
TRUFI Axial and Coronal 
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CAUSES OF BILIARY OBSTRUCTION 
In our study causes of biliary obstruction was divided into 
five major types. 
1) Calculus-Gallbladder calculus, Common bileduct calculus 
2) Stricture- Benign stricture due to post cholecystectomy, 
Malignant stricture due to Klatskin tumour, sclerosing 
cholangitis 
3) Tumour- Gallbladder ca, Pancreatic ca, Periampullary ca, 
Cholangioca 
4) Choledochal cyst 
5) Extrinsic causes –Chronic pancreatitis, Mirizzi’s syndrome, 
Pseudocyst of pancreas 
 
 26
STATISTICAL ANALYSIS  
Data was analysed using Statistical Package for the Social 
Science (SPSS) Version 16.00 for Windows. Descriptive 
(frequencies, Percentages, Mean and Standard Deviation) and 
inferential Statistics were used to analyze the data. The inferential 
statistics used included Chi square, analysis of Variance, 
correlation coefficient.  
Continuous variables were presented as mean ± (SD). 
Continuous variables were compared through student independent 
t-test, Categorical variables by chi-square test was done where 
applicable.  Sensitivity, specificity, PPV , NPV , Accuracy were 
also calculated in comparing diagnosis. For all statistical tests P 
<0.05 was considered as statistically significant. 
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RESULT AND ANALYSIS  
The data were collected from a sample of 50 patients. this  
part deals with the analysis and interpretation of data collected.  
The study subjects consisted of 28 male and 22 female 
patients, between the age of 24 to 60 years (with mean age of 43.56 
± 8.49 years).  
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THE DISTRIBUTION OF DEMOGRAPHICAL 
CHARACTERISTICS OF STUDY SAMPLE 
Table-1: Gender Distribution 
MRCP ERCP 
Gender 
N % N % 
Male 28 56 28 56 
Female 22 44 22 44 
Total  50 100 50 100 
From the above table-1, a total sample of 50 was used for 
analysis. Males comprised 28 (56 %) and female 22 (44 %) of the 
total 50 cases. Same subjects were included both MRCP and ERCP 
study.   Majority of them were males.  
Gender Distribution 
Male
56%
Female
44%
Male Female  
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Table-2: Age distribution 
Male Female Total Age Group 
(in Years ) N % N % N % 
20 – 30 2 7.15 3 13.64 5 10.00 
31 – 40 10 35.71 5 22.73 15 30.00 
41 - 50 8 28.57 10 45.45 18 36.00 
51 – 60 8 28.57 4 18.18 12 24.00 
Total 28 100 22 100 50 100 
 Chi Square= 2.74        p=0.43 
Not Significant 
  
Table -2 reveals that distribution of the age group. 18 (36 %) are in the 
age group of 41–50 years, Irrespective of their sex. Further it reveals that 15 (30 
%) of the patients belong to the age group of 31–40 years, 12 (24 %) of the 
patients belongs to the 51-60 years of the age group and 5 (10 %) are in the age 
group of 20-30 years. Using chi-square test, it showing that there is no significant 
difference between genders. (chi square =2.74 P >0.05). 
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Table3: Mean Age 
 Male Female Total 
Mean 43.82 43.23 43.56 
Standard Deviation 
(Sd) 
7.92 9.35 8.49 
 t-value = 0.243    p=0.809   Not 
Significant 
The mean age of the whole group was 43.56 ± 8.49. Males 
had mean age of  (43.82 ± 7.92 ) and  Females had mean age of  
43.23 ± 9.35.  There is no significant difference between the age of 
the male and female. ( t=0.243  P >0.05). 
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Table-4: Clinical Presentation (Complaints) 
Male Female Total 
Complaints 
N % N % N % 
Obstructive 
Jaundice 
11 39.29 11 50.00 22 44.00
Pain Abdomen 10 35.71 11 50.00 21 42.00
Cholangitis  7 25.00 0 0   7 14.00
Total 28 100 22 100 50 100 
 Chi Square= 6.42  df=2     
p=0.04 
Significant 
  
Table-4 shows that, 22 (44 %) had the complaints of the 
obstructive Jaundice, 21 (42 %) had Pain Abdomen and a small 7 (14 %) 
had Cholangitis. It is clear that the male and female patients differ with 
regards to their complaints ( X2=6.42 , df =2,  P < 0.04). 
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Table-5: MRCP based on Cause of obstruction 
Male Female Total  
 
Cause of Obstruction 
No. % No. % No, % 
1 
BS-PC 
-Benign Stricture -  
Post Cholecystectomy 
2 7.10 5 22.70 7 14.00
2 
C-CA 
-Cholangio Carcinoma 
0 0 1 4.50 1 2.00 
3 
CC  
-CBD Calculus 
3 10.70 1 4.50 4 8.00 
4 
CH-P 
-Chronic Pancreatitis 
3 10.70 0 0 3 6.00 
5 
Ch-Cy 
-Choledochal Cyst 
2 7.10 3 13.60 5 10.00
6 G-CA -Gall Bladder   Carcinoma 4 14.30 0 0 4 8.00 
7 
GC+CC 
-GB Calculus +  
CBD Calculus 
2 7.10 0 0 2 4.00 
8 
MI-SY 
-Mirizzi syndrome 
2 7.10 0 0 2 4.00 
9 
MS-KT 
-Malignant Stricture -  
Klatskin Tumour 
1 3.60 5 22.70 6 12.00
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Male Female Total  
 
Cause of Obstruction 
No. % No. % No, % 
10 
PA-CA 
- Pancreatic Carcinoma 
2 7.10 0 0 2 4.00 
11 PC- Periampullary  carcinoma 3 10.70 3 13.60 6 12.00
12 PS-CH-Primary Sclerosing Cholangitis 1 3.60 1 3.60 2 4.00 
13 Normal 3 10.70 3 13.60 6 12.00
Total 28 100 22 100 50 100 
From the above table, Irrespective of  of their sex  7 (14 %) 
are having  Benign Stricture with  Post Cholecystectomy,6 (14 %) 
are having Malignant stricture with Klatskin Tumour , 6 (14 %) are 
having Periampullary carcinoma, 5 (10 %) are having Choledochal 
Cyst, 4 (8 %) are having Gall Bladder Carcinoma, 3 (6 %) are 
having Chronic Pancreatitis, 2 (4%) are having GB Calculus with  
CBD Calculus, 2 (4 %) are having Mirizzi syndrome, 2 (4 %) are 
having Primary Sclerosing Cholangitis , 1 (2%) is having  
Cholangio Carcinoma and  6 ( 12.%) are not having any disease 
(Normal).  
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Table-6: MRCP – type of causes 
Type of causes No. % 
CALCULUS    6 12.00 
STRICTURE 15 30.00 
TUMORS 13 26.00 
CYST 5 10.00 
EXTRINSIC CAUSES 5 10.00 
Not Determined 6 12.00 
Total 50 100 
Table reveals that type of causes , 15 ( 30 %) was found to be 
Stricture, 13 (26 %) was found to be Tumors, Calculus found in 6 
(12 %), Cyst and Extrinsic Causes are having each 5  (10%) and  6 
(10 %) was found not having any disease ( Not Determined ). 
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Table -7: MRCP in Extent of Obstruction 
Obstruct N % 
Determined 44 88.00 
Not Determined  6 12.00 
Total 50 100 
The above table reveals that extent of obstruction determined 
by MRCP. 44 (98 %) are determined and remaining very few 6 (12 
%) cases are not determined by MRCP. So most of the cases were 
determined by MRCP. 
MRCP Extent of Obstruction 
Determined
88%
Not Determined
12%
Determined Not Determined
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Table 8: ERCP based on Cause of obstruction 
Male Female Total 
S . No. Cause of  Obstruction 
No. % No. % N % 
1 
BS-PC  
-Benign Stricture  
- Post Cholecystectomy 
2 7.10 4 18.20 6 12.00
2 
C-CA 
-Cholangio Carcinoma 
- - 1 4.50 1 2.00 
3 
CC  
-CBD Calculus 
4 14.30 2 9.10 6 12.00
4 
CH-P-  
Chronic Pancreatitis 
3 10.70 0 0 3 6.00 
5 
Ch-Cy 
-Choledochal Cyst 
2 7.10 3 13.60 5 10.00
6 
G-CA 
-GalL Bladder   
Carcinoma 
4 14.30 - - 4 8.00 
7 
GC-CC 
-GB Calculus + CBD  
Calculus 
2 7.10 0 - 2 4.00 
8 
MI-SY 
-Mirizzi syndrome 
2 7.10 0 - 2 4.00 
9 
MS-KT 
-Malignant Stricture  
- Klatskin Tumour 
1 3.60 5 22.70 8 16.00
10 
PA-CA 
- Pancreatic Carcinoma 
2 10.71 - - 2 4.00 
11 PC - Periampullary  carcinoma 3 10.71 2 9.10 5 10.00
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Male Female Total 
S . No. Cause of  Obstruction 
No. % No. % N % 
12 PS-CH -Primary Sclerosing  Cholangitis 0 - 1 4.55 1 2.00 
13 Normal 3 10.70 4 18.20 7 14.0 
Total 28 100.00 22 100.00 50 100.00
From the above table, Irrespective of  their sex  8 (16 %) are 
having  Malignant stricture due to  Klatskin Tumour , 6 (12 %) are having  
Benign Stricture due to  Post Cholecystectomy sequelae, 6 (12 %)  are 
having  CBD calculus, 5 (10 %) are having Choledochal Cyst,  5 (10 % ) 
Periampullary  carcinoma,4 (8%) Gall Bladder  Carcinoma, 3 (6%) 
Chronic Pancreatitis, 2 (4 %)  GB Calculus + CBD Calculus, 2 (4%) 
Mirizzi syndrome,    2 (4 %) Pancreatic Carcinoma, 1 (2 %)  Primary 
Sclerosing Cholangitis and  7 (14 %) were free from disease.  
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Table-9: ERCP in  Cause of obstruction 
Type  of causes No. % 
CALCULUS  8 16.00 
STRICTURE 13 26.00 
TUMORS 12 24.00 
CYST 5 10.00 
EXTRINSIC CAUSES 5 10.00 
Not Determined  7 14.00 
Total 50 100 
The above table reveals that ERCP was able to detect 
Calculus in 8 (16 %) cases, Stricture in 13 (26%) cases, Tumors in 
12 (24 %) cases, Cyst in 5 (10 %) cases,  Extrinsic Causes in   5 (10 
%) cases and 7 (14 %) were free from disease.    
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Table-10: ERCP in Extent of Obstruction 
Obstruction N % 
Determined 36 72 
Not Determined  14 28 
Total 50 100 
The above Table-10 Reveals that extent of obstruction 
determined by ERCP was 36 cases (72 %) and remaining 14 (28%) 
are not determined by ERCP.   
ERCP Extent of Obstruction 
Determined
72%
Not Determined
28%
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Table-11: Per Operative Findings 
Male Female Total 
 Cause of Obstruction 
No. % No. % No, % 
1 BS-PC -Benign Stricture  - Post Cholecystectomy 2 7.10 4 18.20 6 12.00
2 
C-CA 
-Cholangio Carcinoma 
0 0 1 4.50 1 2.00 
3 
CC  
-CBD Calculus 
3 10.70 1 4.50 4 8.00 
4 CH-P – Chronic Pancreatitis  3 10.70 0 0.00 3 6.00 
5 
Ch-Cy 
-Choledochal Cyst 
2 7.10 3 13.60 5 10.00
6 
G-CA 
-Gall Bladder  Carcinoma 
4 14.30 0 0 4 8.00 
7 
GC+CC 
-GB Calculus + CBD Calculus
2 7.10 0 0 2 4.00 
8 
MI-SY 
-Mirizzi syndrome 
2 7.10 0 0 2 4.00 
9 MS-KT -Malignant Stricture  - Klatskin Tumour 2 7.10 5 22.70 7 14.00
10 
PA-CA 
- Pancreatic Carcinoma 
2 10.70 0 - 2 4.00 
11 
PC  
- Periampullary carcinoma 
3 10.70 3 13.60 6 12.00
12 PS-CH -Primary Sclerosing  Cholaigitis 1 3.60 1 4.50 2 4.00 
13 Normal 2 7.10 4 18.20 6 24.00
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Male Female Total 
 Cause of Obstruction 
No. % No. % No, % 
 Total 28 100 22 100 50 100 
From the above  table shows per operative findings , Irrespective of  of 
their sex  7 (14 %) are having Malignant stricture with Klatskin Tumour , 6 (12 
%) are having  Benign Stricture  due to Post Cholecystectomy, 6 (12 %) are 
having  Periampullary carcinoma, 5 (10 %) are  having Choledochal Cyst, 4 (8 
%) are having Gall Bladder  Carcinoma, 3 (6 %) are having Chronic 
Pancreatitis, 2 (4 %) are  having GB Calculus + CBD Calculus, 2 (4 %) are 
having  Mirizzi syndrome, 2 (4 %) are  having Pancreatic Carcinoma,  1 (2%) 
is  having Cholangio Carcinoma and  6 (12 %) free from disease  ( Normal). 
Peroperative Cause of Obstruction 
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Table-12: Per Operative  determination. 
TYPE TOTAL 
CALCULUS 6 
STRICTURE 15 
TUMORS 13 
CYST 5 
EXTRINSIC CAUSES 5 
Non Diseased  6 
TOTAL 50 
The above table reveals that Operative  findings confirmed 
Calculus in 6 (12 %) cases, Stricture in 15 (30%) cases, Tumors in 
13 (26 %) cases, Cyst in 5 (10 %) cases,  Extrinsic Causes in   5 (10 
%) cases and 6 (12 %) were free from disease.    
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Table-13: Per Operative  Extent of Obstruction 
Obstruction N % 
Diseased  44 88 
Non Diseased  06 12 
Total 50 100 
The above Table-13 Reveals that extent of obstruction  
determined in per Operative findings. 44 cases (88 %) are having 
Disease and remaining 6 (12%)  are not having  disease.   
Peroperative extent of obstruction 
Diseased
88%
Non Diseased
12%
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Table-14: MRCP – Cause Vs Extent of obstruction 
Obstruction 
Sl No. Cause 
Determined Not Determined 
Total
1 BS-PC- Benign Stricture - Post Cholecystectomy 7 0 7 
2 C-CA- Cholangio  Carcinoma 1 0 1 
3 
CC –  
CBD Calculus 
4 0 4 
4 
Ch-Cy 
Choledochal Cyst 
5 0 5 
5 CH-P – Chronic  Pancreatitis  3 0 3 
6 G-CA- Gall Bladder  + Carcinoma 4 0 4 
7 GC+CC- GB Calculus  + CBD Calculus 2 0 2 
8 
MI-SY- 
Mirizzi syndrome 
2 0 2 
9 
MS-KT- Malignant  
Stricture  
+ Klatskin Tumour 
6 1 7 
10 
PA-CA-  
Pancreatic Carcinoma 
2 0 2 
11 
PC –  
Periampullary carcinoma
6 0 6 
12 PS-CH- Primary  Sclerosing +Cholangitis 2 0 3 
13 Normal 0 5 5 
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Obstruction 
Sl No. Cause 
Determined Not Determined 
Total
TOTAL 44 6 50 
Table shows that MRCP detected obstruction in 44 (88 %) 
cases but failed  in 6 (12 %) cases. 
MRCP Cause Vs Extent of Obstruction 
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Table-15: ERCP – Cause Vs Extent of Obstruction 
Obstruction 
 Causes 
Determined Not Determined Total
1. BS-PC- Benign Stricture  
+ Post Cholecystectomy 6 0 6 
2. C-CA- 
Cholangio Carcinoma 1 0 1 
3. CC – CBD Calculus 6 0 6 
4. CH-P – Chronic Pancreatitis 3 0 3 
5. Ch-Cy 
Choledochal Cyst 0 5 5 
6. G-CA- 
Gall Bladder  Carcinoma 4 0 4 
7. GC+CC- GB Calculus  
+ CBD Calculus 2 0 2 
8. MI-SY- 
Mirizzi syndrome 0 2 2 
9. MS-KT-Malignant Stricture 
- Klatskin Tumour 6 1 7 
10. PA-CA-  
Pancreatic Carcinoma 2 0 2 
11. PC –  
Periampullary carcinoma 5 0 5 
12. PS-CH- Primary  
SclerosingCholangitis 1 0 1 
13. Normal 0 6 6 
Total 36 14 50 
Table shows that  ERCP was not able to detect  14 (28 %) 
cases but correctly detect 36 (72 %) cases. Among  not able to 
detect cases 5 were (10 %) Choledochal Cyst , 2 (4 %)  Mirizzi 
syndrome and  7 (14 %)  Normal cases.                                                 
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Table-16: Comparison between MRCP and ERCP  in  Cause of 
obstruction vs Extent of obstruction. 
Determined Not Determined S 
No 
Per Operative 
Findings 
 
N 
MRCP ERCP MRCP ERCP
1 
BS-PC- Benign 
Stricture - Post 
Cholecystectomy 
6 6 6 0 0 
2 C-CA- Cholangio Carcinoma 1 1 1 0 0 
3 CC – CBD Calculus 4 4 4 0 0 
4 CH-P –  Chronic Pancreatitis 3 3 3 0 0 
5 Ch-Cy- Choledochal Cyst 5 5 0 0 5 
6 G-CA- Gall Bladder  Carcinoma 4 4 4 0 0 
7 GC+CC-GB Calculus + CBD Calculus 2 2 2 0 0 
8 MI-SY- Mirizzi syndrome 2 2 0 0 2 
9 
MS-KT- Malignant 
Stricture - Klatskin 
Tumour 
7 6 6 1 1 
10 PA-CA-  Pancreatic Carcinoma 2 2 2 0 0 
11 PC –  Periampullary carcinoma 6 6 5 0 1 
12 
PS-CH- 
Primary 
SclerosingCholangitis 
2 2 1 0 1 
13 Normal 6 1 2 5 4 
Total 50 44 36 6 14 
Both MRCP and ERCP failed to detect some cases. They are   
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Malignant Stricture - Klatskin Tumour  and Normal cases.  
MRCP failed to detect 1 (2 %) Malignant Stricture - Klatskin 
Tumour and 5 (10 %) normal  cases. But ERCP failed  to detect  5 (10 %) 
cases of Choledochal Cyst, 2 (4 %) Mirizzi syndrome, 1 (2 %) Malignant 
Stricture - Klatskin Tumour, 1 (2 %) in  Periampullary , 1 (2%)  in  
Primary Sclerosing Cholangitis and 4 (8 %) cases  as normal.  
In contrast to MRCP, ERCP fails to detect  14 cases.  
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Table-17: Comparison between MRCP and ERCP in Determining the 
Extent of obstruction by Type of Causes 
Determined Not Determined Per Operative Findings 
Type 
N 
MRCP ERCP MRCP ERCP 
CALCULUS    6 6 6 0 0 
STRICTURE 15 14 13 1 2 
TUMORS 13 13 12 0 1 
CYST   5 5 0 0 5 
EXTRINSIC CAUSES   5 5 3 0 2 
Non Disease    6 1 2 5 4 
Total 50 44 36 6 14 
Both MRCP and ERCP were fails to detect some type of 
causes. They are 2 % cases of stricture  and 10% cases of normal in 
MRCP..ERCP has failed in detecting cases in all most all the type 
expect Calculus. 
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Table-18: Sensitivity of MRCP with peroperative findings 
Per  Operative Findings 
MRCP 
Disease Present Disease absent 
Total 
Test Positive 
(Determined) 
43 1 44 
Test Negative 
(Not Determined) 
1 5 6 
TOTAL 44 6 50 
Sensitivity  =   97.73 %  
Specificity  =   83.33  % 
Positive Predictive Value  ( PPV)     =     97.73  % 
Negative Predictive Value (NPV)     =     83.33  % 
False Positive Rate (FPR)  =  14.29 % 
False Negative Rate (FNR)  = 2.27 % 
Accuracy (ACC) = 96 % 
MRCP is detecting 97.73 % of positive cases and 83 .33 % 
negative cases were correctly detecting.   
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a. Under the nonparametric assumption 
b. Null hypothesis: true area = 0.5 
 53
CO-ORDINATES OF THE CURVE 
Test Result Variable(s):MRCP - Extent of  Obstruction 
Positive if Greater 
Than or Equal Toa Sensitivity 1 - Specificity 
.00 1.000 1.000 
1.50 .023 .833 
3.00 .000 .000 
The test result variable(s): MRCP - Extent of Obstruction   
has  at least one tie between the positive actual state group and the 
negative actual state group. 
a. The smallest cutoff value is the minimum observed test 
value minus 1, and the largest cutoff value is the maximum 
observed test value plus 1. All the other cutoff values are the 
averages of two consecutive ordered observed test values. 
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Table -19: Sensitivity  of  ERCP with per Operative Findings  
Per Operative Findings 
ERCP Disease 
Present Disease Absent 
Total 
Determined 34 2 36 
Not Determined 10 4 14 
TOTAL 44 6 50 
Sensitivity  =   77.27%  
Specificity  =   66.67 % 
Positive Predictive Value  ( PPV)     =    97.44 % 
Negative Predictive Value (NPV)     =    28.57 % 
False Positive Rate (FPR) =  33.33% 
False Negative Rate (FNR) = 22.73% 
Accuracy (ACC) (ACC) = 76 % 
ERCP is detecting 77.27 % of positive cases and 66.67% 
negative cases are correctly detecting.   
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ERCP sensitivity and specificity 
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Area Under the Curve Test Result Variable(s):ERCP - Extent of  
Obstruction 
Asymptotic 95% Confidence 
Interval 
Area Std. Errora Asymptotic Sigb 
Lower Bound Upper Bound
.280 .119 .083 .048 .513 
The test result variable(s): ERCP - Extent of  Obstruction  has 
at least one tie between the positive actual state group and the 
negative actual state group. Statistics may be biased. 
a. Under the nonparametric assumption 
b. Null hypothesis: true area = 0.5 
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Coordinates of the Curve Test Result Variable(s):ERCP - Extent of  
Obstruction 
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity
.00 1.000 1.000 
1.50 .227 .667 
3.00 .000 .000 
The test result variable(s): ERCP - Extent of  Obstruction  has 
at least one tie between the positive actual state group and the 
negative actual state group. 
a. The smallest cutoff value is the minimum observed test 
value minus 1, and the largest cutoff value is the maximum  
observed  test value  plus 1. All the other cutoff values are the 
averages of two consecutive ordered observed test values. 
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Table-20 
 MRCP ERCP 
Sensitivity 97.73   % 77.27   % 
Specificity 83.33   % 66.67   % 
Positive Predictive Value ( PPV) 97.73   % 97.44   % 
Negative Predictive Value (NPV) 83.33   % 28.57   % 
False Positive Rate (FPR) 14.29   % 33.33   % 
False Negative Rate (FNR) 2.27   % 22.73   % 
Accuracy (ACC) 96.00   % 76.00 % 
While comparing MRCP and ERCP all the values were higher 
then the ERCP values expect False Negative Rate ( FNR). From 
that we can concluded that MRCP is clearly showing superior to 
ERCP in mapping out the extent of obstruction.     
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CASE 1-DISTAL CBD CALCULUS 
 
TRUFI coronal image shows dilated bileduct with filling defect noted 
in distal CBD. 
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ERCP-DISTAL CBD CALCULUS 
 
ERCP shows a filling defect at distal CBD 
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CASE2- PERIAMPULLARY CARCINOMA 
T2 HASTE 
 
TRUFI CORONAL 
 
Figure shows IHBR dilatation.dilatedCBD. 
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CASE 3-DISTAL CBD STRICTURE 
 
Figure shows dilated CBD with abrupt narrowing of terminal CBD. 
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ERCP-DISTAL CBD STRICTURE 
 
Due to the narrowing of terminal CBD the scope not passed beyond 
terminal CBD.
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CASE4-DISTAL CBD GROWTH 
 
T2 Haste 
 
Trufi Coronal 
Figure shows stent in CBD. Circumferential thickening of distal CBD 
noted.-BLOCKED STENT with Distal CBD growth 
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CASE 5-TYPE 1 CHOLEDOCHAL CYST 
 
Figure shows Fusiform dilatation CBD noted 
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CASE 6-TYPE 4 CHOLEDOCHAL CYST 
 
  Figure shows  d ilatation of both intrahepatic and 
extrahepatic bileduct  noted. 
 Left hepatic duct and common bileduct appears dilated. 
 Rt hepatic duct appears normal 
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CASE 7-KLATSKIN TUMOR 
 
T2 image shows isointense lesion noted in the confluence of 
hepaticducts.CBD appears normal. 
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ERCP-KLATSKIN TUMOR 
 
Filling defect noted in the hilum .normal appearing CBD.IHBR 
dilatation. 
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CASE 8-ACUTE ON CHRONIC PANCREATITIS 
 
 Figure shows Pseudo cyst, Pancreatic ascities, Duct disruption with 
Communication  to cyst noted 
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CASE9-ERCP-SHORT SEGMENT STRICTURE 
 
ERCP  shows short segment stricture at the level of cystic duct after  
post cholecystectomy 
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CASE 10-ERCP PALLIATIVE STENT PLACEMENT 
 
ERCP-Metallic stent placement in a case of inoperable periampullary 
growth 
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BISMUTH-CORLETTE CLASSIFICATION 
 
Bismuth classification of malignant hilar biliary obstruction based on 
proximal extent of tumour 
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TODANI CLASSIFICATION OF CHOLECOCHAL CYST 
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DISCUSSION 
Fifty evaluation of biliary patients – 28 males and 22 females 
were included in our study.  A sizeable percentage ( 36 %) of  the 
patients belongs to the age group  41 -50 years. Mean age of  the 
whole group was  43.56 ± 8.49.   
44 % with the complaints of Obstructive Jaundice followed 
by 42 % with  Pain Abdomen and 14 %  with Cholangitis. There is 
no significant difference between male and female. Highest  44 % 
of them had complaints of  Obstructive Jaundice. 
MRCP was able to detect Cause and type of  Stricture in 30 % 
cases, Tumours in 26 % cases, Calculus  in 12 % cases, 10 % in  
Extrinsic cases ,10  %  of  cases in Cyst cases and 12% cases of  
Non Disease cases, most of  the obstructive jaundice cases were 
occurred from Stricture.  
ERCP was able to detect Cause and type of  Stricture in 26 % 
cases, Tumours in 24 % cases, Calculus  cause in 6 % , Extrinsic 
causes in 10% cases,  and 14 % of  cases form non Disease cases. 
Most of  the  obstructive jaundice were occurred from Stricture.  
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Comparison of  MRCP with ERCP based on Cause of  
Obstruction. MRCP was Determined  Calclulus in 6 (12 % )  cases 
and also ERCP was picked up 6 ( 12 %) cases. No cases were 
missed by both.. In Stricture MRCP has missed 1 (2 %) cases but 
ERCP has failed to Determined  2 ( 4 %) cases.  ERCP  has missed 
to diagnosis  1 tumor ( 2 % ) cases, 5 cyst cases( 10 %) and 2 cases 
of extrinsic causes(4 %) but MRCP  was not missed  such a cases.  
One case of stricture due to klatskin tumour was not 
diagnosed by both MRCP and ERCP. The stricture was short 
segment one. It is due to periductal cause. One case of 
periampullary growth was missed by ERCP  .It  was a small non 
obstructive growth of terminal CBD at the level of periampullary 
region.It was also predominantly an extraluminal growth.One case 
of stricture was diagnosed at MRCP but preoperative finding came 
as normal.We false positively diagnosed  the narrowing as 
stricture.5 cases of choledochal cyst and 2 cases of mirizzi 
syndrome were not diagnosed by ERCP.2 cases of stricture was 
misdiagnosed by ERCP due to underfilling of duct.Due to technical 
errors like endoscope distorting the distal bile duct,contrast 
material extravasation,overlapping of bowel gas,incomplete filling 
of ducts,contrast media induced allergic reactions,10 cases 
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were not diagnosed by ERCP .One  case of stricture due to 
sclerosing cholangitis was not diagnosed by ERCP.The stricture 
was very narrow one.Of the 6 cases that were normal 
preoperatively,MRCP correctly detected 5 cases to be normal and 
ERCP correctly detected 4 cases to be normal.They had medical 
causes of abdominal pain. 
MRCP was able to  diagnosis  44 ( 88 % ) cases against 6 ( 12 % ) 
cases were missed to diagnose the extent of obstruction.. In ERCP  36 (72 
%) were diagnosed but 14 ( 28 %) cases were missed to determine the 
extent of obstruction.  In our study MRCP was  able to diagnose   more  
cases than  ERCP and also the extent of obstruction.      
In our study MRCP has 97.73 % sensitivity, 83.33 % 
Specificity & 96 % accuracy rate.   ERCP has 83.33 % sensitivity, 
66.67 % Specificity and accuracy in 76 %   in determining the 
cause and extent of obstruction.  
In our study MRCP’s Sensitivity level (97.73 %)  is more 
than  ERCP (83.33 %) .  MRCP determine accurately more cases 
than ERCP in both cause and extent of obstruction. 
From that we can say that  MRCP is superior to ERCP in 
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mapping out the extent of obstruction . This is use full in planning 
further management of the disease. Thus MRCP may replace ERCP 
for diagnostic purposes. ERCP may then be reserved for patients 
who required intervention in treating biliary obstruction. 
MRCP is a comparable diagnostic investigation in 
comparison to ERCP for diagnosing biliary abnormalities. Results 
were particularly favourable for choledocholethiasis ,stricture 
,malignancy and choledochal cyst .Less favourable for pancreatitis.  
The use of MRCP reduces the need for diagnostic ERCP which is 
associated with significant morbidity and mortality.  
Magnetic Resonance Cholangio Pancratography (MRCP) is 
superior imaging modality when compared with Endoscopic 
Retrograde Cholangio Pancretography (ERCP) mainly because it is  
1) Non invasive procedure 
2) No radiation  required  
3) Anaesthesia is not required 
4) Less operator dependent 
5) Can be performed in patients in Whom endoscope access is 
unavailable or unsuccessful.    
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6) Demonstrates anatomic variants preoperatively. 
7) It can give a detailed map of  biliary tree allowing visualization 
of ducts proximals as well as distal to the level of obstruction 
8) Can show the extent of lesion more accurately than ERCP.  
The real benefits of ERCP, include: 
1) ability to offer therapeutic intervention at the time of the 
diagnostic procedure; 
2) Manometry can be performed; 
3) The ampulla of Vater can be directly visualized; 
4) The radiographic images obtained with ERCP have a higher 
spatial resolution.. 
Diagnostic ERCP is primarily used to demonstrate bile duct 
and cystic duct leaks. 
Direct tissue sampling, can be performed during ERCP 
5% of all ERCP attempts, have complications  including pancreatitis, 
hemorrhage , gastrointestinaltract   perforation, and hemorrhage . 
 Contrast media induced allergic reactions is a major 
drawback in Diagnostic ERCP. 
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PIT FALLS OF MRCP 
 Pitfalls include pseudo–filling defects, pseudodilatations, and 
non-visualization of the ducts. 
 Pseudofilling defects   are usually due to stones, air, tumors, 
hemorrhage, or sludge. Infrequent causes of filling defects 
include susceptibility artifact from adjacent clips, metallic 
bile duct stents, folds or flow voids. 
 Pseudodilatations can occur if the cystic duct crosses the 
common bile duct or courses parallel to it or if extraductal 
fluid-filled structures (eg, intestine, pseudocysts, gallbladder) 
are volume averaged with the ducts. 
 Nonvisualization of the intrahepatic bile ducts may be a 
normal finding due to nondistention; however, 
nonvisualization of the extrahepatic bile ducts may be due to 
obscuration by extraductal fluid-filled structures (eg, 
intestine, pseudocysts, gallbladder), intravenous 
administration of manganese, or pneumobilia. 
 65
PITFALLS OF ERCP 
1) Pancreatic duct in the head of the pancreas may take a steep 
downward course to the papilla, paralleling the common bile 
duct. In this circumstance a partially filled pancreatic duct 
can be confused with the bile duct on fluoroscopy. 
2) The main pancreatic duct is occasionally narrowed at its 
junction with the accessory duct; it is important not to 
misinterpret this normal variant asa duct stricture. 
3) ERCP artifacts may be caused by endoscopic equipment (e.g., 
pressure from the cannula or endoscope distorting the distal bile 
duct), contrast material injected outside the ductal systems, 
nonpancreaticobiliary calcifications, bowel gas overlyingthe area 
of interest, incomplete filling of ducts, and unintentional 
injection of air. 
4) Pancreatic duct artifacts are commonly caused by inadvertent 
contrast injection in an inappropriate location. Unintentional 
cannulation of a pancreatic duct side branch followed by 
contrast injection can lead to branch duct rupture and contrast 
extravasation . 
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5) Pancreatic duct underfilling is a frequent cause of erroneous 
diagnosis of ductal stricture or obstruction, usually when the 
tail has not been opacified. 
6) Injection of contrast material that is too dense, particularly 
into a dilated duct, may obscure small calculi.Dilute contrast 
material is preferable when calculi are suspected,especially in 
a dilated common duct .  
7) A contracted biliary sphincter may mimic a stricture or 
calculus of the distal bile duct. 
8) Streaming of contrast material in the bile duct refers to 
contrast material flowing along the dependent wall of a 
dilated duct rather than completely filling the lumen. This 
effect causes an illusion of normal caliber when the duct is 
dilated further contrast injection shows the true size of the 
duct. 
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CONCLUSION 
MRCP has highest sensitivity, specificity, and diagnostic 
accuracy than ERCP in diagnosing  obstruction  due to  
pancreaticobiliary disorders. MRCP is able to determine accurately 
more cases than ERCP in both cause and extent of  obstruction. 
Anatomy of biliary tree is well delineated by MRCP. Bileducts 
proximal as well as distal to the level of obstruction is made out 
better by MRCP. Due to invasiveness and contrast media induced 
allergic reactions, diagnostic usage of ERCP is limited .ERCP is 
mainly reserved for patients who required intervention in treating 
biliary obstruction. 
From this we can conclude that MRCP is more sensitive and 
specific in diagnosing pancreaticobiliary disorders than ERCP. 
ERCP is mainly used for therapeutic purposes. 
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 PROFORMA 
Accuracy of Magnetic  resonance  
cholangiopancreatography Vs Endoscopic retrograde 
cholangiopancreatography in the evaluation of 
pancreaticobiliary disorders 
Sl. No :     Date: 
Name:      IP No: 
Age/ Sex:      Occupation: 
Address:  
Presenting Complaints 
Yellowish discolouration of skin : 
Dark coloured urine : 
Clar coloured stools : 
Pruritis : 
Fever : 
Nausea and Vomiting : 
Abdomen Pain : 
Abdomen Mass : 
Loss of Appetite : 
Loss of weight : 
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Past History 
H/o. Abdominal Surgery : 
Vital Signs 
Pulse : 
BP : 
General Examination 
   Yes  No 
Built : 
Anaemia : 
Jaundice : 
Lymphadenopathy : 
Examination of Abdomen 
Abdomen Tenderness : 
Abdomen Mass : 
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DEPARTMENT OF GASTROENTEROLOGY
RAJIV GANDHI GOVT. GENERAL HOSPITAL, CHENNAI-3. 
ERCP
(Endoscopic Retrograde Cholangio Pancreatography) 
Name:    Age/ Sex:   IP No: 
Diagnosis:        Date: 
Indication(s):     Premedications: 
Upper GI Endoscopy 
Procedure 
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1.5 TESLA  SIEMENS MRI 
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ENDOSCOPY 
 
C-ARM FLUORO UNIT 
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GUIDEWIRE 
 
BIOPSY FORCEPS 
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IOHEXOL 
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ABBREVIATIONS 
OJ-Obstructive Jaundice 
PA-Pain abdomen 
C-Cholangitis 
CC-Common bile duct calculus 
GC+CC-Gallbladder calculus+Common bile duct calculus 
BS-PC-Benign stricture-Post Cholecystectomy 
MS-KT-Malignant stricture-Klatskin tumour 
PC-Periampullary Carcinoma 
PA-C-Pancreatic Carcinoma 
G-Ca-Gallbladder Carcinoma 
C-Ca-Cholangiocarcinoma 
CH-P-Chronic pancreatitis 
Ch-Cy-Choledochal cyst 
PS-Ch-Primary Sclerosing Cholangitis 
Mi-Sy-Mirizzi Syndrome 
D-Determined 
ND-Not Determined 
SSFSE-Single Shot Fast Spin Echo 
SSFP-Steady State Free Precession 
FOV-Field of view 
RAO-Right Anterior Oblique 
LAO-Left Anterior Oblique 
PTC-Percutaneous Transhepatic Cholangiography 
HASTE- Half fourier acquisition with turbo spin echo 
TRUFI- True free inducti9n with steady precession 
SD-Standard Deviation 
PPV-Positive Predictive Value 
NPV-Negative Predictive Value 
ROC-Receiver Operating Characteristic 
- 
 
Cause of Obstr Extent  of Obstruction Cause of Obst Extent  of Obstruction
1 Muthammal 42 F OJ PC D ND ND PC
2 Veerammal 58 F PA BS-PC D ND ND NORMAL
3 Selvam 52 M PA ND ND CC D NORMAL
4 Ramesh 36 M PA Ch-Cy D Ch-Cy ND Ch-Cy
5 Muhesh 40 M OJ CC D CC D CC
6 Pandi 52 M OJ G.Ca D G.Ca D G.Ca
7 Mohanraj 46 M PA CH-P D CH-P D CH-P
8 Annam 58 F OJ C.Ca D C.Ca D C.Ca
9 Sampath 42 M C PC D PC D PC
10 Vijaya 39 F OJ MS-KT D MS-KT D MS-KT
11 Kotti 46 M C BS-PC D BS-PC D BS-PC
12 Kathirvelu 39 M C Pa-C D Pa-C D Pa-C
13 Kumar 52 M OJ GC+CC D GC+CC D GC+CC
14 Rani 29 F PA Ch-Cy D Ch-Cy ND Ch-Cy
15 Mahesh 39 M C CC D CC D CC
16 Valli 46 F PA BS-PC D BS-PC D BS-PC
17 Jamuna 39 F OJ MS-KT D MS-KT D MS-KT
18 Mani 46 M OJ PC D PC D PC
19 Devi 42 F PA BS-PC D BS-PC D BS-PC
20 Sivaraj 52 M OJ G.Ca D G.Ca D G.Ca
21 Muthu 39 M PA Mi-Sy D Mi-Sy ND Mi-sy
22 Kannagi 46 F OJ MS-KT D MS-KT D MS-KT
23 Selvi 49 F OJ PC D PC D PC
24 Mariammal 52 F PA ND ND CC D NORMAL
AgeNameS.No Peroperative findings
MRCP ERCP
Presenting complaintsSex
25 Sundar 39 M OJ G.Ca D G.Ca D G.Ca
26 Kannan 29 M PA Ch-Cy D Ch-Cy ND Ch-Cy
27 Vanitha 46 F PA PS-Ch D Ps-Ch D Ps-Ch
28 Prasanna 45 M PA GC+CC D GC+CC D GC+CC
29 Ravi 29 M OJ CC D CC D CC
30 Senthil 60 M PA CH-P D CH-P D CH-P
31 Abdul 54 M C ND ND ND ND NORMAL
32 Manohari 54 F OJ MS-KT D MS-KT D MS-KT
33 Sumathi 46 F PA BS-PC D BS-PC D BS-PC
34 Mehala 24 F PA Ch-Cy D Ch-Cy ND Ch-Cy
35 Vadivelu 52 M OJ ND ND ND ND MS-KT
36 Kumutha 49 F OJ CC D CC D CC
37 Kamatchi 36 F PA ND ND ND ND NORMAL
38 Priyanka 39 F PA BS-PC D BS-PC D BS-PC
39 Seetha 42 F OJ PC D PC D PC
40 Saravanan 56 M OJ MS-KT D MS-KT D MS-KT
41 Muthukumar 46 M PA Mi-Sy D Mi-Sy ND Mi-sy
42 Vajravelu 33 M C Pa-C D Pa-C D Pa-C
43 Dhinakar 39 M PA Ps-Ch D ND ND Ps-Ch
44 Hariprasadh 41 M PA CH-P D CH-P D CH-P
45 Senthil Kuma 40 M OJ BS-PC D BS-PC D BS-PC
46 Kalyani 39 F PA ND ND ND ND NORMAL
47 Rajamani 46 F OJ MS-KT D MS-KT D MS-KT
48 Gopalan 37 M OJ G-Ca D G-Ca D G-Ca
49 Sukumar 46 M C PC D PC D PC
50 Sudha 26 F OJ Ch-Cy D Ch-Cy ND Ch-Cy
Mi-Sy- Mirizzi Syndrome
OJ- Obstructive Jaundice
PA- Pain Abdomen
C- Chalangitis
CC- Common Bile Duct Calculus
GC+ CC- GB calculus & CBD Calculus
BS-PC- Benign Sticture- Post Cholecystectomy
MS-KT: Malignant Stricture- Klatskin Tumour
PC- Periampullary Carcinoma
G.Ca- Gall Bladder Carcinoma
Pa-.Ca- Pancreatic Carcinoma
C-Ca- Cholangio Carcinoma
CH-P-Chronic pancreatitis
Ch-Cy- Choledochal cyst
Ps-Ch- Primary Sclerosing Cholangitis
D- Determined
ND- Not determined
ABSTRACT 
Aim of the study 
A study on accuracy of Magnetic Resonance Cholangio 
Pancreatography{MRCP} Vs Endoscopic Retrograde Cholangio 
Pancreatography [ERCP] in Pancreatico Biliary Disorders 
Materials and Methods 
 Study design: prospective  study 
 Place: Barnard Institute of Radiology, Rajivgandhi government 
general hospital. Madras Medical College, Chennai-3 
 Collaborating Unit: Department of Medical Gastroenterology, 
Rajivgandhi government general hospital. Madras Medical College, 
Chennai-3 
Study population 50 patients were included in the study. The study 
group consisted of  male and female patients, between the age of 22 to 
65 years (with a mean age of 43 years). For all 50 patients per 
operative findings were obtained.The study was Approved by the 
ethical committee . 
 Sample Size:50  
  Consent     -Informed  consent obtained  from all patients   
    Inclusion Criteria  
   Patients who were having a history of obstructive jaundice,pain 
abdomen and cholangitis  
 50 patients with  these symptoms underwent MRCP using 1.5 Tesla 
Siemens Symphony MRI scanner. 
 The same patientswere underwent  ERCP,and the results were  
 Compared with preoperative findings. 
  Exclusion Criteria                                         
 Pts with claustrophobia 
 Pts with cardiac pacemakers 
 Pts with cochlear implants 
 Hemodynamically unstable patients  
Causes of biliary obstruction 
In our study causes of biliary obstruction was divided into 5 types like 
calculus,stricture,tumour,cyst,and extrinsic causes. 
Results 
VARIABLE MRCP ERCP 
Sensitivity  97.72% 77.27% 
Specificity  83% 66.66% 
Positive Predictive Value  97.72% 94.44% 
Accuracy 96% 76% 
 
Discussion 
Comparison of  MRCP with ERCP based on Cause of  Obstruction. MRCP was 
Determined  Calclulus in 6 (12 % )  cases and also ERCP was picked up 6 ( 12 
%) cases. No cases were missed by both.. In stricture MRCP has missed 1 (2 %) 
cases but ERCP has failed to Determined  2 ( 4 %) cases.  ERCP  has missed to 
diagnosis  1 tumor ( 2 % ) cases, 5 cyst cases( 10 %) and 2 cases of extrinsic 
causes(4 %) but MRCP  was not missed  such a cases. MRCP was able to  
diagnosis  44 ( 88 % ) cases against 6 ( 12 % ) cases were missed to diagnose 
the extent of obstruction.. In ERCP  36 (72 %) were diagnosed but 14 ( 28 %) 
cases were missed to determine the extent of obstruction.  In our study MRCP 
was  able to diagnose   more  cases than  ERCP and also the extent of 
obstruction. In our study MRCP has 97.73 % sensitivity, 83.33 % Specificity & 
96 % accuracy rate.   ERCP has 83.33 % sensitivity, 66.67 % Specificity and 
accuracy in 76 %   in determining the cause and extent of obstruction. In our 
study MRCP’s Sensitivity level (97.73 %)  is more than  ERCP (83.33 %) .  
MRCP determine accurately more cases than ERCP in both cause and extent of 
obstruction. 
Conclusion 
 MRCP  has highest  sensitivity, specificity,and diagnostic accuracy than  ERCP 
in diagnosing  obstruction  due to  pancreaticobiliary disorders. MRCP  is able 
to determine  accurately more cases than ERCP in both cause and extent of  
obstruction. Anatomy of biliary tree is well  delineated  by MRCP .Bileducts  
proximal as well as distal to the level of obstruction is made out better by 
MRCP. Due to invasiveness and contrast media induced allergic 
reactions,diagnostic usage of ERCP is limited .ERCP is mainly reserved for 
patients who required intervention in treating biliary obstruction. 
From this we can conclude that MRCP is more sensitive and specific in  
diagnosing  pancreaticobiliary  disorders than ERCP.ERCP is mainly used for 
therapeutic purposes. 
